Abstract #2301

Choline kinase-α downregulation decreases prostate cancer associated fibroblast viability

Jesus Pacheco-Torres¹, Flonne Wildes¹, Tariq Shah¹, Balaji Krishnamachary ¹, and Zaver M Bhujwalla^1,2,3

¹Division of Cancer Imaging Research, The Russell H. Morgan Department of Radiology and Radiological Science. The Johns Hopkins University School of Medicine, Baltimore, MD, United States, ²Sidney Kimmel Comprehensive Cancer Center. The Johns Hopkins University School of Medicine, Baltimore, MD, United States, ³Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, United States

Cancer associated fibroblasts (CAFs) significantly influence the proliferation, invasion, and metastasis of cancer cells. CAFs are detected in most tumors and provide a ubiquitous target that is being actively investigated in cancer treatment. In prostate cancer, fibroblasts have been shown to induce growth, confer castration-resistance, and increase metastatic potential. Choline kinase (Chk)-α downregulation has been previously shown to significantly decrease cancer cell viability but its effect on CAFs has not been investigated before. Here we found, for the first time, a significant decrease of prostate cancer fibroblast (PCAF) viability with Chk-α downregulation.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.